COX-2 inhibitors: exemplars of the drug-safety conundrum

Med J Aust. 2005 Mar 21;182(6):262-3. doi: 10.5694/j.1326-5377.2005.tb06695.x.

Abstract

Using clinical trials to assess long-term drug safety is problematic; in Australia, simple data linkage based on Medicare numbers may provide useful monitoring information.

Publication types

  • Editorial

MeSH terms

  • Australia
  • Clinical Trials as Topic / methods
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Drug Evaluation / methods
  • Humans
  • National Health Programs
  • Product Surveillance, Postmarketing / methods*

Substances

  • Cyclooxygenase Inhibitors